× InvestingStocksToolsClubsVideosPrivacy PolicyTerms And Conditions
Subscribe To Our Newsletter

The Best Monkeypox Stocks To Watch If Outbreak Continues

||


The monkeypox outbreak is raising red flags for the American healthcare system. In fact, vaccines and antiviral treatments are hard to come by at the current moment. This is why investors are pinpointing specific companies that are prepared to help fight the virus. The best monkeypox stocks have a head start making vaccines and providing antiviral treatment.

Cases are rising throughout the world due to international travel and the scarcity of proper treatment. Therefore, which companies are beginning to develop vaccines and antiviral medications to fight this growing threat? Let’s take a closer look at monkeypox and the companies that are preparing to make a difference.


Bavarian Nordic is one of the best monkeypox stocks

The Best Monkeypox Stocks: How Did We Get Here?

Believe it or not, monkeypox was first discovered in 1958 when a disease was recognized in monkeys kept for research in Copenhagen, Denmark. According to the CDC, it’s a rare disease that is caused by infection with the monkeypox virus.

The first human case was recorded in 1970. In addition, most cases since have come within Africa. Cases outside of Africa began to appear due to international travel and the importation of animals.

Now there are outbreaks around the world and the spread doesn’t seem to be slowing down. However, there are a limited amount of vaccines available. This is why you may want to keep a close watch on the companies that are on the frontlines of treatment. Below are the best monkeypox stocks to invest in right now.

3. Moderna Inc (Nasdaq: MRNA)

Moderna is the creator of one of the most prominent COVID-19 vaccines in America. However, it’s also beginning to investigate the “potential of monkeypox vaccines at a preclinical level,” according to a recent post on its Twitter account.

This is huge news, as Moderna is already one of the biggest players in the biotech space. Along with its production of COVID-19 vaccines and booster shots, Moderna may be the perfect fit for your portfolio. It’s down more than 50% in the past year and is trading around $160 at the moment. With a 52-week high of $497.49, buying low is tempting many investors who are looking for the best monkeypox stocks moving forward.

2. Emergent Biosolutions (NYSE: EBS)

Emergent Biosolutions is a Maryland-based biopharmaceutical company. And it makes the top of this list due to its smallpox vaccine, ACAM2000®. Specifically, ACAM2000® is expected to be effective against monkeypox due to its close relation to the variola virus. This is the same virus that causes smallpox.

Moreover, a recent announcement is giving Emergent more leverage and power as the monkeypox outbreak continues to surge. The company is acquiring the rights to TEMBEXA®, a smallpox antiviral treatment, in a $225 million deal with Chimerix (Nasdaq: CMRX).

The viability of smallpox treatments for use against monkeypox is gaining steam. And this is why Emergent is one of the best monkeypox stocks to consider right now. It’s trading around $34 at the moment and it’s up roughly 10% in the past month.

Keep Reading This Article and Find Out the Best Monkeypox Stock Right Now


Enter your email below to reveal the best monkeypox stock on this list.
You’ll also be opted in to receive our free daily e-letter, Investment U, where you’ll find expert investment insight, analysis and stock picks for all the best investment opportunities.

You’ll also receive occasional special offers from Oxford Club and our affiliates. You can unsubscribe at any time. Privacy Policy | Newsletter FAQ

"); } else if (data['response'] == 'Already Active On List') { // email already exists in system send confirmation anyway $(".status").html("